<DOC>
	<DOCNO>NCT00142181</DOCNO>
	<brief_summary>The purpose study determine safety effect ( good bad ) Campath-1H antibody treatment lymphoplasmacytic lymphoma .</brief_summary>
	<brief_title>Phase II Study Campath-1H Antibody Treat Waldenstrom 's Macroglobulinemia</brief_title>
	<detailed_description>- Patients receive 3 test dos Campath-1H ( 3mg , 10mg , 30mg ) . If patient tolerates three test dos , receive total 6 week Campath-1H therapy three time week . - After patient receives first 6 week therapy 30mg therapeutic dose re-assessed blood testing . If determined disease progress period time patient Campath-1H , patient remove study . - If determine patient achieve complete remission 6 week Campath-1H treatment bone marrow biopsy perform confirm complete remission patient receive additional treatment follow period 2 year . - If disease remain stable partial response achieve patient enter second phase therapy receive additional 6 week Campath-1H therapy . The patient reassess describe . - No additional therapy ( part study ) perform 12 week course Campath-1H . - While patient Campath-1H blood test perform 3-6 month interval period extend 2 year follow last treatment . Bone marrow biopsy and/or aspiration conduct necessary .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Waldenstrom Macroglobulinemia</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Alemtuzumab</mesh_term>
	<criteria>Diagnosis lymphoplasmacytic lymphoma include patient Waldenstrom 's macroglobulinemia Adequate organ function : ANC &gt; 500/ul ; PLT &gt; 25,000/ul ; serum creatinine &lt; 2.5 ; serum total bilirubin SGOT &lt; 2.5 time upper normal limit . Age great 18 year Life expectancy 6 month great ECOG performance status 02 Chemotherapy , steroid therapy , radiation therapy within 21 day study entry . Prior Campath1H monoclonal antibody therapy within 3 month study entry . Pregnant woman Serious comorbid disease , uncontrolled bacterial , fungal , viral infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Lymphoplasmacytic lymphoma</keyword>
	<keyword>Waldenstrom 's Macroglobulinemia</keyword>
	<keyword>Antibody</keyword>
	<keyword>Campath-1H</keyword>
</DOC>